Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
06/11/2008 | CN101198253A Combinations, methods and compositions for treating cancer |
06/11/2008 | CN100393713C Therapeutic agents useful for treating pain |
06/11/2008 | CN100393706C Substituted dihydrochinazolines having antiviral properties |
06/11/2008 | CN100393703C 1,2,3,4-tetrahydroisoquinoline derivatives |
06/10/2008 | US7385063 Method for preparing imidazole derivatives |
06/10/2008 | US7385053 Functionalized compositions for improved immobilization |
06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
06/10/2008 | CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents |
06/05/2008 | WO2008067440A2 Rosuvastatin dehydroabietylamine salt |
06/05/2008 | WO2008067219A2 Quinazolinone modulators of tgr5 |
06/05/2008 | WO2008065445A1 Amino quinazolines derivatives wuth blood platelet reducing properties |
06/05/2008 | WO2008065410A1 Process for the preparation of rosuvastatin |
06/05/2008 | WO2008065393A1 Hydantoin derivatives used as mmp inhibitors |
06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
06/05/2008 | US20080132699 Process For the Preparation of Diazine Derivatives |
06/05/2008 | US20080132698 Use of N-oxide compounds in coupling reactions |
06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
06/05/2008 | US20080132514 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity |
06/05/2008 | US20080132513 new mechanism of action, oral bioavailability and/or reduced side effects; Ca2+-release-activated Ca2+ channels inhibitors; IL-2, IL-4, IL-5, IL-13, GM-CSF, TNF- alpha , and IFN gamma inhibitors; immunosuppressant |
06/05/2008 | US20080132507 Hydrazide Derivatives |
06/05/2008 | US20080132504 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders |
06/05/2008 | US20080132499 Platelet adp receptor inhibitors |
06/05/2008 | US20080132497 Novel Heterocycles |
06/05/2008 | US20080132412 7-Amino-6-Heteroaryl-1,2,4-Triazolo[1,5-A]Pyrimidines and Their Use for Controlling Harmful Fungi |
06/05/2008 | DE19946341B4 Verfahren zur Herstellung substituierter Phenylsulfonylharnstoffe aus Sulfohalogeniden A process for the preparation of substituted phenylsulfonylureas of Sulfohalogeniden |
06/05/2008 | CA2670456A1 Process for the preparation of rosuvastatin |
06/05/2008 | CA2670168A1 Amino quinazolines derivatives wuth blood platelet reducing properties |
06/05/2008 | CA2670166A1 Hydantoin derivatives used as mmp inhibitors |
06/04/2008 | EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
06/04/2008 | EP1926716A1 Process for synthesis of aryloxy diaminopyrimidines |
06/04/2008 | EP1926715A1 Pesticide pyrimidinyloxy substituted phenylamidine derivatives |
06/04/2008 | EP1926500A2 Methods of making radiolabeled tracers and precursors thereof |
06/04/2008 | EP1841745B1 Process for the manufacture of a precursor of vitamin b1 |
06/04/2008 | EP1395591B1 Corticotropin releasing factor antagonists |
06/04/2008 | EP1368412B1 Imageable element and composition comprising thermally reversible polymers |
06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
06/04/2008 | EP1193250B1 Phenyl sulfamate derivatives |
06/04/2008 | CN101193985A Cyanine coloring matter and optical recording medium |
06/04/2008 | CN101193868A Pyrimidine derivatives for the treatment of GABA B mediated nervous system disorders |
06/04/2008 | CN101193635A Multicyclic compounds and methods of their use |
06/04/2008 | CN101190899A Method for synthesizing 1.2-dihydroquinazolin-4(3H)-one compound |
06/04/2008 | CN101190898A Preparation method for 1.3-dimethylbarbituric acid |
06/04/2008 | CN101190897A Method for synthesizing 4-(4-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-formic acid ester |
06/04/2008 | CN100391959C Pyrimidine-5-(1H)-ketone derivative |
06/03/2008 | US7381828 Forming a salt such as a tartrate or mandelate of 6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]-dioxol-4-yl]oxy}-1-ethanol, chemical intermediates |
06/03/2008 | US7381730 Bone disorders, cardiovascular diseases, anticholesterol agents, hypertriglyceridemia, vasomotor disorders, urogenital disorders, prostatic hypertrophy, endometrial hyperplasia, anticarcinogenic agents; CNS disorders; side effect reduced |
06/03/2008 | US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders |
06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
06/03/2008 | CA2203237C Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
05/29/2008 | WO2008063668A1 Heterobicyclic metalloprotease inhibitors |
05/29/2008 | WO2008062907A1 Substance capable of inhibiting cytokinin signaling |
05/29/2008 | WO2008062859A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production |
05/29/2008 | WO2008062276A2 Acetylene derivatives as stearoyl coa desaturase inhibitors |
05/29/2008 | WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives |
05/29/2008 | WO2008062011A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
05/29/2008 | WO2008061740A1 Pyrimidines and their use as cxcr2 receptor antagonists |
05/29/2008 | US20080125589 Process for Production of Fluoro Derivative |
05/29/2008 | US20080125468 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses |
05/29/2008 | US20080125449 hypotensive agent; cardiovascular disease; 5-ethoxycarbonyl-4-(2-ethoxy-6-pentadecylphenyl)-6-methyl-3,4 -dihydropyrimidin-2(1H)-one; |
05/29/2008 | US20080125448 Quinazoline Based EGFR Inhibitors Containing a Zinc Binding Moiety |
05/29/2008 | US20080125429 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents |
05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
05/29/2008 | US20080125417 4-Tert-Butyl-N-(2-methyl-3-{2-[4-(morpholine-4-carbonyl)-phenylamino]-pyrimidin-4-yl}-phenyl)-benzamide;enzyme inhibitors of Burton's tyrosine kinase (Btk); autoimmune diseases; antiinflammatory/-arthritic agents; X-linked agammaglobulinaemia; antiallergens; osteoporosis; determining the presence Btk |
05/29/2008 | US20080124384 Heteroaryl Substituted Piperazinyl-Pyridine Analogues |
05/29/2008 | CA2670143A1 Pyrimidines and their use as cxcr2 receptor antagonists |
05/29/2008 | CA2670031A1 Heterobicyclic metalloprotease inhibitors |
05/29/2008 | CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives |
05/29/2008 | CA2669275A1 Agent for inhibiting cytokinin signaling |
05/29/2008 | CA2668567A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
05/28/2008 | EP1924573A1 B-raf inhibitors |
05/28/2008 | EP1924568A1 Quinazoline derivatives useful in cancer treatment |
05/28/2008 | EP1924567A2 Process for the preparation of pyrimidinedione derivatives |
05/28/2008 | EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
05/28/2008 | EP1924565A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators |
05/28/2008 | EP1924564A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
05/28/2008 | EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
05/28/2008 | EP1404668B1 Variolin derivatives and their use as antitumor agents |
05/28/2008 | CN100390235C Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
05/28/2008 | CN100390146C Process for making risperidone and intermediates therefor |
05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/27/2008 | US7378522 Such as 6-(4-Acetamidophenoxy)-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid-ethyl ester; rapid effectiveness, bioavailability; low cost, simple synthesis |
05/27/2008 | US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
05/27/2008 | US7378424 Derivatives of pyrimido[6, 1-A]isoquinolin-4-one |
05/27/2008 | US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
05/22/2008 | WO2008059519A2 A process for the preparation of intermediates of rosuvastatin |
05/22/2008 | WO2008059024A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
05/22/2008 | WO2006055561A3 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
05/22/2008 | US20080119651 Process For The Production Of Pyrimidine-5-Carboxylates |
05/22/2008 | US20080119486 Benzoyl-piperazine derivatives |
05/22/2008 | US20080119473 3-[4-(4-Fluoro-phenyl)-[1,3,5]triazin-2-yl]-benzoic acid; suppressing premature translation termination associated with nonsense mutation in an mRNA; diseases associated with nonsense mutations in mRNA; antiinflammatory, anticarcinogenic, antidiabetic agent; autoimmune, neurodegenerative diseases |
05/22/2008 | US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract |
05/22/2008 | CA2669867A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
05/22/2008 | CA2666837A1 Arylsulfonamide compounds |
05/21/2008 | EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
05/21/2008 | EP1922309A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
05/21/2008 | EP1922306A2 Amide derivatives as rock inhibitors |